AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 216 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $748,000 | -1.8% | 26,458 | -23.0% | 0.05% | +24.3% |
| Q2 2022 | $762,000 | +24.9% | 34,365 | +64.0% | 0.04% | +8.8% |
| Q1 2022 | $610,000 | -35.9% | 20,954 | -27.6% | 0.03% | -2.9% |
| Q4 2021 | $951,000 | +23.2% | 28,931 | +73.0% | 0.04% | -12.5% |
| Q3 2021 | $772,000 | -15.6% | 16,724 | +0.8% | 0.04% | +2.6% |
| Q2 2021 | $915,000 | +286.1% | 16,597 | +204.0% | 0.04% | +95.0% |
| Q4 2020 | $237,000 | -49.1% | 5,460 | -58.9% | 0.02% | -60.8% |
| Q3 2020 | $466,000 | +31.6% | 13,300 | +101.0% | 0.05% | -13.6% |
| Q2 2020 | $354,000 | +26.4% | 6,617 | +12.8% | 0.06% | +156.5% |
| Q4 2019 | $280,000 | -67.9% | 5,865 | -66.5% | 0.02% | -69.7% |
| Q2 2019 | $873,000 | – | 17,510 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |